Radio and PodcastLive Radio & Podcasts

Search Radio and Podcast

Podcasts›Biotech 2050 Podcast›Johan Luthman, Lundbeck EVP R&D, on Rebuilding Neuroscience Pipelines & Drug Discovery

Science & Medicine

Johan Luthman, Lundbeck EVP R&D, on Rebuilding Neuroscience Pipelines & Drug Discovery

Biotech 2050 Podcast by Biotech2050 Podcast

Jan 27, 202600:31:02Science & Medicine

Synopsis: Fresh from the JPM 2026 in San Francisco, Alok Tayi welcomes Johan Luthman, Executive Vice President of R&D at Lundbeck, for a sweeping, deeply personal conversation on the future of neuroscience drug developme...

Related Episodes

Continue listening to more episodes from Biotech 2050 Podcast.

Nick Myerberg, Partner & Head of AI at Braidwell on AI's Next Era in Drug Discovery

Aug 3, 2026 - 00:47:40

Synopsis: The guest on today's podcast is a representative of Braidwell LP, a registered investment advis...

Robert Jacks, CEO of Sparrow Pharmaceuticals Precision Medicine, Biotech Strategy & Leadership

Jul 22, 2026 - 00:34:19

Synopsis: In an industry often defined by rapid innovation and high-stakes science, long-term success in...

Ardelyx Leaders Mike Raab & Laura Williams on Building Biotech Around Patients

Jun 10, 2026 - 00:41:21

Synopsis: While biotech is increasingly measured by clinical milestones and financial outcomes, Rahul Cha...

Acadia CEO Catherine Owen Adams on Neurodegeneration, AI & Building Biotech Vision

May 13, 2026 - 00:33:34

Synopsis: At the intersection of personal mission and biotech leadership, Rahul Chaturvedi sits down with...

Barry Quart, CEO of Connect Biopharma, on Asthma Innovation & Biotech Leadership

Apr 16, 2026 - 00:23:07

Synopsis: This episode is proudly sponsored by Quartzy. At a time when biotech innovation is being reshap...

Adial CEO Cary Claiborne on Treating Alcohol Addiction with Genetics

Mar 6, 2026 - 00:14:16

Synopsis: Addiction is often misunderstood as a failure of willpower—but emerging science increasingly sh...

Sheila Gujrathi, MD on Leadership, Biotech Innovation & The Mirror Effect for Women Leaders

Mar 5, 2026 - 00:39:59

Synopsis: This episode is proudly sponsored by Quartzy. Physician-scientist, biotech founder, and leaders...

Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms

Feb 11, 2026 - 00:25:06

Synopsis: At the heart of JPM 2026’s biotech buzz, Alok Tayi sits down with Fred Aslan, CEO of Artiva, to...